Form 4: GeneDx Holdings Corp. CFO Kevin Feeley Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Kevin Feeley, CFO of GeneDx Holdings Corp., reports the acquisition and disposition of Class A Common Stock related to the vesting and settlement of Restricted Stock Units (RSUs).

Summary

  • On April 29, 2024, Kevin Feeley, the CFO of GeneDx Holdings Corp., engaged in transactions involving the company's Class A Common Stock.
  • Feeley acquired 3,013 shares of Class A Common Stock upon the vesting of Restricted Stock Units (RSUs) at a price of $0.
  • Simultaneously, Feeley sold 1,104 shares of Class A Common Stock at a price of $11.0368 per share to cover tax withholding obligations related to the RSU vesting.
  • Following these transactions, Feeley directly owns 30,836 shares of Class A Common Stock and 6,026 Restricted Stock Units.
  • The sales were to satisfy tax withholding obligations to be funded by a 'sell to cover' transaction.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects routine stock transactions related to executive compensation. There is no indication of positive or negative implications for the company's performance.

Future Outlook

The remaining RSUs will continue to vest quarterly, subject to the Reporting Person's continued service to the Issuer.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, providing transparency to investors regarding the executive's holdings and transactions in the company's stock.

Stakeholder Impact

  • The transactions provide transparency to shareholders regarding executive compensation and stock ownership.
  • The sale of shares to cover tax obligations has a minor impact on the stock's trading volume.

Key Dates

DateDescription
04/29/202325% of the underlying shares of the Restricted Stock Units vested.
04/29/2024Transactions occurred: acquisition of 3,013 shares via RSU vesting and sale of 1,104 shares to cover tax obligations; 25% of the underlying shares of the Restricted Stock Units vested.
04/30/2024Date of signature by Attorney-in-Fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.